(VIANEWS) – SPBK1 NORD-NORGE (NONG.OL), GAMING INNOVATION (GIG.OL), MONTEA (MONT.BR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SPBK1 NORD-NORGE (NONG.OL)
30.3% sales growth and 13.71% return on equity
SpareBank 1 Nord-Norge provides banking services in Northern Norway. It operates through Retail Market, Corporate Market, Leasing, and Markets segments. The company offers mortgage, car, vehicle, and other loan related services. It also offers vehicle, home, travel, personal, and pet insurance services. In addition, the company provides various savings and pension related services, as well as debit and credit card services. Further, it offers financing, real estate leasing, agency, payment, and investment services. The company was founded in 1836 and is headquartered in Tromsø, Norway.
Earnings Per Share
As for profitability, SPBK1 NORD-NORGE has a trailing twelve months EPS of kr9.38.
PE Ratio
SPBK1 NORD-NORGE has a trailing twelve months price to earnings ratio of 10.28. Meaning, the purchaser of the share is investing kr10.28 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.71%.
More news about SPBK1 NORD-NORGE.
2. GAMING INNOVATION (GIG.OL)
28.9% sales growth and 17.73% return on equity
Gaming Innovation Group Inc., an iGaming technology company, together with its subsidiaries, provides solutions, products, and services to iGaming operators in Nordic countries, other European countries, and internationally. It operates through two segments, Platform Offering Front-End Services (Platform), and Affiliate Marketing (Media). The company offers media services, such as operating various content rich websites, which empower potential players and connect them with online casino or sports betting sites; and platform services, including igaming platform solutions and services to operators and their customers, as well as undertakes land-based operators online through its omnichannel solution, which brings together the offline and online worlds through a shared loyalty system and wallets. It also provides Sportsbook, a sports betting omnichannel solution that offers a various digital content and sports events to players. In addition, the company offers managed service; omnichannel solutions; Data platform to enhance BI and make business decisions; Logic, a real-time rules engine that creates actionable business rules; marketing compliance solution; and Frontend solution. Gaming Innovation Group Inc. was founded in 2012 and is headquartered in St. Julian's, Malta.
Earnings Per Share
As for profitability, GAMING INNOVATION has a trailing twelve months EPS of kr0.83.
PE Ratio
GAMING INNOVATION has a trailing twelve months price to earnings ratio of 30.12. Meaning, the purchaser of the share is investing kr30.12 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.73%.
More news about GAMING INNOVATION.
3. MONTEA (MONT.BR)
25.8% sales growth and 10.57% return on equity
Montea NV is a public regulated real estate company under Belgian law (GVV/SIR) that specialises in logistical property in Belgium, the Netherlands, France, and Germany. The company is a benchmark player in this market. Montea literally offers its customers the space they need to grow through versatile and innovative property solutions. In this way, Montea creates value for its shareholders. As of 31/03/2023 the property portfolio represented a total space of 1,889,054 m² spread across 92 locations. Montea NV has been listed on Euronext Brussels (MONT) and Euronext Paris (MONTP) since the end of 2006.
Earnings Per Share
As for profitability, MONTEA has a trailing twelve months EPS of €7.75.
PE Ratio
MONTEA has a trailing twelve months price to earnings ratio of 9.29. Meaning, the purchaser of the share is investing €9.29 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.57%.
More news about MONTEA.
4. NAVAMEDIC (NAVA.OL)
21.8% sales growth and 22.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.75.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 22.29. Meaning, the purchaser of the share is investing kr22.29 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.
Moving Average
NAVAMEDIC’s worth is above its 50-day moving average of kr38.10 and above its 200-day moving average of kr35.78.
Volume
Today’s last reported volume for NAVAMEDIC is 3790 which is 88.53% below its average volume of 33048.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr39.00 at 17:20 EST, way below its 52-week high of kr43.60 and way above its 52-week low of kr26.00.
More news about NAVAMEDIC.
5. ABN AMRO BANK N.V. (ABN.AS)
19.6% sales growth and 9.3% return on equity
ABN AMRO Bank N.V. provides various banking products and services to retail, private, and business clients in the Netherlands and internationally. It operates through three segments: Personal & Business Banking, Wealth Management, and Corporate Banking. The company provides savings and deposits products; labelled residential mortgage products under the Florius brands; and consumer loans under the Alpha Credit Nederland, Credivance, Defam, Moneyou, and ABN AMRO brands. It also issues, promotes, manages, and processes credit cards; provides revolving credit card facilities and pension schemes, as well as consumer credit and mortgages; and life and non-life insurance products. In addition, it offers asset-based solutions, including working capital solutions, equipment leases and loans, and vendor lease services; private banking and wealth-management-related services; and derivatives and equity clearing services. ABN AMRO Bank N.V. was incorporated in 2009 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ABN AMRO BANK N.V. has a trailing twelve months EPS of €2.21.
PE Ratio
ABN AMRO BANK N.V. has a trailing twelve months price to earnings ratio of 6.59. Meaning, the purchaser of the share is investing €6.59 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.3%.
Volume
Today’s last reported volume for ABN AMRO BANK N.V. is 611435 which is 78.56% below its average volume of 2852860.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 18% and a drop 30% for the next.
More news about ABN AMRO BANK N.V..
6. AIRBUS (AIR.PA)
14.7% sales growth and 53.48% return on equity
Airbus SE engages in the design, manufacture, and delivery of aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft; freighter aircraft; and regional turboprop aircraft and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment engages in the development, manufacture, marketing, and sale of civil and military helicopters; and provision of helicopter related services. The Airbus Defence and Space segment designs, develops, delivers, and supports military aircraft, such as combat, mission, transport, tanker aircraft, and their associated services; a range of civil and defence space systems for telecommunications, earth observations, navigation, science, and orbital systems; and unmanned aerial systems. This segment also offers missile and space launcher systems, as well as services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. Airbus SE was incorporated in 1998 and is based in Leiden, the Netherlands.
Earnings Per Share
As for profitability, AIRBUS has a trailing twelve months EPS of €4.46.
PE Ratio
AIRBUS has a trailing twelve months price to earnings ratio of 29.75. Meaning, the purchaser of the share is investing €29.75 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.48%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 26.5%, now sitting on 55.11B for the twelve trailing months.
More news about AIRBUS.
